SENS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	927 974
Średni wolumen	2.55M
Kapitalizacja rynkowa	220.60M
EPS	$0 ( 2024-02-29 )
Następna data zysków	( $-0.0232 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.78
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-02	Prince Douglas S	Buy	15 931	Common Stock
2024-04-02	Fiorentino Edward	Buy	27 696	Common Stock
2024-04-02	Steven Edelman	Buy	25 245	Common Stock
2024-03-20	Hansen Brian B	Sell	2 619 048	Stock Option (Right to Buy)
2024-01-02	Defalco Stephen P	Buy	42 410	Common Stock

INSIDER POWER
5.84
Last 98 transactions
Buy: 13 341 086 \| Sell: 71 889 452

Wolumen Korelacja

Długi: -0.34 (neutral)

Krótki: -0.17 (neutral)

Signal:(32.152) Neutral

Senseonics Holdings Inc Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Senseonics Holdings Inc Korelacja - Waluta/Towar

0.00
( neutral )

0.44
( neutral )

Senseonics Holdings Inc Finanse

Annual	2023
Przychody:	$22.39M
Zysk brutto:	$3.09M (13.81 %)
EPS:	$-0.110

FY	2023
Przychody:	$22.39M
Zysk brutto:	$3.09M (13.81 %)
EPS:	$-0.110

FY	2022
Przychody:	$16.39M
Zysk brutto:	$2.73M (16.63 %)
EPS:	$0.300

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.720

Financial Reports:

No articles found.

Senseonics Holdings Inc

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.